Twin Tree Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-36,182
Closed -$5.65M 1906
2020
Q4
$5.65M Buy
36,182
+16,274
+82% +$2.09M 0.23% 587
2020
Q3
$2.28M Sell
19,908
-38,750
-66% -$4.18M 0.13% 742
2020
Q2
$6.58M Sell
58,658
-111,039
-65% -$11.8M 0.33% 577
2020
Q1
$15.2M Buy
169,697
+154,085
+987% +$15.1M 0.73% 233
2019
Q4
$1.69M Buy
+15,612
New +$1.67M 0.11% 761
2019
Q3
Hold
0
1774
2019
Q2
Sell
-3,605
Closed -$465K 1808
2019
Q1
$487K Sell
3,605
-58,625
-94% -$7.29M 0.04% 953
2018
Q4
$6.06M Buy
62,230
+53,905
+648% +$6.37M 0.36% 450
2018
Q3
$1.16M Sell
8,325
-4,395
-35% -$551K 0.1% 693
2018
Q2
$1.58M Buy
+12,720
New +$1.49M 0.1% 689
2018
Q1
Sell
-78,195
Closed -$9.35M 1503
2017
Q4
$9.35M Buy
78,195
+55,573
+246% +$6.77M 0.8% 252
2017
Q3
$3.17M Buy
+22,622
New +$3.07M 0.39% 481
2017
Q2
Sell
-2,129
Closed -$248K 1332
2017
Q1
$258K Buy
+2,129
New +$274K 0.03% 824
2016
Q4
Hold
0
1501
2016
Q3
Sell
-24,119
Closed -$3.1M 1463
2016
Q2
$2.82M Buy
+24,119
New +$3.42M 0.58% 392
2016
Q1
Sell
-6,951
Closed -$1.33M 1657
2015
Q4
$1.33M Buy
6,951
+3,450
+99% +$603K 0.32% 550
2015
Q3
$548K Buy
+3,501
New +$639K 0.18% 751
2015
Q2
Sell
-6,281
Closed -$1.08M 1560
2015
Q1
$1.09M Buy
6,281
+906
+17% +$164K 0.4% 567
2014
Q4
$995K Buy
5,375
+2,641
+97% +$489K 0.31% 590
2014
Q3
$453K Sell
2,734
-4,911
-64% -$806K 0.15% 727
2014
Q2
$1.2M Buy
+7,645
New +$1.21M 0.41% 543
2014
Q1
Sell
-2,123
Closed -$338K 1212
2013
Q4
$282K Buy
+2,123
New +$255K 0.13% 800

Other funds holding ALXN